Huperzine for Cognitive and Functional Impairment in Schizophrenia
Clinical trial NCT00963846 · COMPLETED
Trial details
- NCT number
- NCT00963846
- Sponsor
- Biomedisyn Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2012-12-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.